Amphastar Pharmaceuticals

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell AMPH and other ETFs, options, and stocks.

About AMPH

Amphastar Pharmaceuticals, Inc. engages in developing, manufacturing, and commercializing technically challenging generic and proprietary injectable, inhalation, and intranasal products, and insulin active pharmaceutical ingredients. It operates through Pharmaceutical Products segment. 

CEO
Yong Feng Zhang
CEOYong Feng Zhang
Employees
1,976
Employees1,976
Headquarters
Rancho Cucamonga, California
HeadquartersRancho Cucamonga, California
Founded
1996
Founded1996
Employees
1,976
Employees1,976

AMPH Key Statistics

Market cap
887.34M
Market cap887.34M
Price-Earnings ratio
11.71
Price-Earnings ratio11.71
Dividend yield
Dividend yield
Average volume
552.86K
Average volume552.86K
High today
$21.06
High today$21.06
Low today
$20.00
Low today$20.00
Open price
$20.02
Open price$20.02
Volume
117.31K
Volume117.31K
52 Week high
$31.26
52 Week high$31.26
52 Week low
$16.65
52 Week low$16.65

Stock Snapshot

With a market cap of 887.34M, Amphastar Pharmaceuticals(AMPH) trades at $20.86. The stock has a price-to-earnings ratio of 11.71.

As of 2026-08-14, Amphastar Pharmaceuticals(AMPH) stock has fluctuated between $20.00 and $21.06. The current price stands at $20.86, placing the stock +4.3% above today's low and -0.9% off the high.

Amphastar Pharmaceuticals(AMPH) shares are trading with a volume of 117.31K, against a daily average of 552.86K.

In the last year, Amphastar Pharmaceuticals(AMPH) shares hit a 52-week high of $31.26 and a 52-week low of $16.65.

In the last year, Amphastar Pharmaceuticals(AMPH) shares hit a 52-week high of $31.26 and a 52-week low of $16.65.

AMPH News

Simply Wall St 7h
Lead Independent Director Richard Prins Sold A Bunch Of Shares In Amphastar Pharmaceuticals

Anyone interested in Amphastar Pharmaceuticals, Inc. ( ) should probably be aware that the Lead Independent Director, Richard Prins, recently divested US$162k w...

Lead Independent Director Richard Prins Sold A Bunch Of Shares In Amphastar Pharmaceuticals
Simply Wall St 7d
Amphastar Pharmaceuticals Stock Rebound Meets Margin Pressure And Valuation Gap

Amphastar Pharmaceuticals stock closed up 4.9% at US$20.78, yet the real story sits behind that modest relief rally. Q2 delivered a sharp earnings snapback, wit...

Amphastar Pharmaceuticals Stock Rebound Meets Margin Pressure And Valuation Gap

Analyst ratings

86%

of 7 ratings
Buy
0%
Hold
85.7%
Sell
14.3%

People also own

Based on the portfolios of people who own AMPH. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.